Emily Jane Cook
Subscribe to Emily Jane Cook's Posts
Emily Jane Cook advises healthcare providers on complex regulatory and reimbursement matters, enabling them to evaluate and mitigate the compliance risks of new business initiatives and existing service lines. As a widely-recognized national authority on the 340B drug pricing program, Emily counsels healthcare providers and other stakeholders on issues related to implementation, compliance and advocacy. Click here to read Emily's full bio: https://www.mwe.com/people/cook-emily-j/
By Emily Jane Cook, Jamie Gelfman, Lisa Mazur and Drew Elizabeth McCormick on Dec 30, 2021
Posted In Enforcement, Telehealth
On December 27, 2020, the No Surprises Act was signed into law as part of the Consolidated Appropriations Act, 2021. In July and October 2021, respectively, the Department of Health and Human Services, the Department of Labor, the Department of the Treasury and the Office of Personnel Management (the Departments) issued two Interim Final Rules...